Radiomics in Kidney Cancer: MR Imaging

Alberto Diaz De Leon III; Payal Kapur; Ivan Pedrosa

doi:10.1016/j.mric.2018.08.005

Radiomics in Kidney Cancer: MR Imaging

Alberto Diaz De Leon III, Payal Kapur, Ivan Pedrosa

Research output: Contribution to journal › Review article › peer-review

40 Scopus citations

Abstract

Renal tumors encompass a heterogeneous disease spectrum, which confounds patient management and treatment. Percutaneous biopsy is limited by an inability to sample every part of the tumor. Radiomics may provide detail beyond what can be achieved from human interpretation. Understanding what new technologies offer will allow radiologists to play a greater role in caring for patients with renal cell carcinoma. In this article, we review the use of radiomics in renal cell carcinoma, in both the pretreatment assessment of renal masses and posttreatment evaluation of renal cell carcinoma, with special emphasis on the use of multiparametric MR imaging datasets.

Original language	English (US)
Pages (from-to)	1-13
Number of pages	13
Journal	Magnetic resonance imaging clinics of North America
Volume	27
Issue number	1
DOIs	https://doi.org/10.1016/j.mric.2018.08.005
State	Published - Feb 2019

Keywords

Kidney cancer
MR imaging
Quantitative imaging
Radiomics

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.mric.2018.08.005

Cite this

@article{c50ea0634e5c42fc987c15f9d3bc7154,

title = "Radiomics in Kidney Cancer: MR Imaging",

abstract = "Renal tumors encompass a heterogeneous disease spectrum, which confounds patient management and treatment. Percutaneous biopsy is limited by an inability to sample every part of the tumor. Radiomics may provide detail beyond what can be achieved from human interpretation. Understanding what new technologies offer will allow radiologists to play a greater role in caring for patients with renal cell carcinoma. In this article, we review the use of radiomics in renal cell carcinoma, in both the pretreatment assessment of renal masses and posttreatment evaluation of renal cell carcinoma, with special emphasis on the use of multiparametric MR imaging datasets.",

keywords = "Kidney cancer, MR imaging, Quantitative imaging, Radiomics",

author = "{Diaz De Leon III}, Alberto and Payal Kapur and Ivan Pedrosa",

note = "Funding Information: This article was supported by NIH Grant U01 CA207091 (I. Pedrosa), P50CA196516 (I. Pedrosa, P. Kapur) and R01CA154475 (I. Pedrosa). Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2019",

month = feb,

doi = "10.1016/j.mric.2018.08.005",

language = "English (US)",

volume = "27",

pages = "1--13",

journal = "Magnetic resonance imaging clinics of North America",

issn = "1064-9689",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Radiomics in Kidney Cancer

T2 - MR Imaging

AU - Diaz De Leon III, Alberto

AU - Kapur, Payal

AU - Pedrosa, Ivan

PY - 2019/2

Y1 - 2019/2

N2 - Renal tumors encompass a heterogeneous disease spectrum, which confounds patient management and treatment. Percutaneous biopsy is limited by an inability to sample every part of the tumor. Radiomics may provide detail beyond what can be achieved from human interpretation. Understanding what new technologies offer will allow radiologists to play a greater role in caring for patients with renal cell carcinoma. In this article, we review the use of radiomics in renal cell carcinoma, in both the pretreatment assessment of renal masses and posttreatment evaluation of renal cell carcinoma, with special emphasis on the use of multiparametric MR imaging datasets.

AB - Renal tumors encompass a heterogeneous disease spectrum, which confounds patient management and treatment. Percutaneous biopsy is limited by an inability to sample every part of the tumor. Radiomics may provide detail beyond what can be achieved from human interpretation. Understanding what new technologies offer will allow radiologists to play a greater role in caring for patients with renal cell carcinoma. In this article, we review the use of radiomics in renal cell carcinoma, in both the pretreatment assessment of renal masses and posttreatment evaluation of renal cell carcinoma, with special emphasis on the use of multiparametric MR imaging datasets.

KW - Kidney cancer

KW - MR imaging

KW - Quantitative imaging

KW - Radiomics

UR - http://www.scopus.com/inward/record.url?scp=85056774649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056774649&partnerID=8YFLogxK

U2 - 10.1016/j.mric.2018.08.005

DO - 10.1016/j.mric.2018.08.005

M3 - Review article

C2 - 30466904

AN - SCOPUS:85056774649

SN - 1064-9689

VL - 27

SP - 1

EP - 13

JO - Magnetic resonance imaging clinics of North America

JF - Magnetic resonance imaging clinics of North America

IS - 1

ER -

Radiomics in Kidney Cancer: MR Imaging

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this